Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

NCT02650401 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
CNS Tumors

Interventions

DRUG: Entrectinib

Sponsor

Hoffmann-La Roche